Position in SVRA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$554,037
+$134,735 QoQ
Shares Held
101,472
+45.9% QoQ
Ownership
0.050%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#75
of 184 holders
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in SVRA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $13,950,986,356 across 255 Biotechnology names. SVRA ranks #176 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
3,374,955 | $2,464,560,888 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,177,527 | $1,682,444,460 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,760,122 | $785,964,877 | |
| 4 | INSM |
INSMED Inc
|
3,092,807 | $505,735,799 | |
| 5 | KYMR |
Kymera Therapeutics, Inc.
|
6,060,847 | $504,807,946 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,432,748 | $474,053,330 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
3,232,213 | $314,332,713 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
6,206,618 | $305,117,340 |
All Filings in SVRA
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $554,037 | 101,472 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $419,302 | 69,536 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $240,689 | 67,420 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $126,920 | 55,667 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $144,377 | 52,122 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $134,060 | 43,668 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $162,951 | 38,432 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $124,865 | 30,984 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $167,786 | 33,692 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $136,614 | 29,067 | Shares | Defined | 2024-02-16 | |
| 2023-09-30 | $103,269 | 27,320 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $113,611 | 35,559 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $56,472 | 28,960 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $44,888 | 28,960 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $44,888 | 28,960 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $34,595 | 22,760 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $28,636 | 21,860 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $21,402 | 17,260 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $23,818 | 17,260 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $29,342 | 17,260 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $39,526 | 19,003 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $13,573 | 11,803 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||